Trials / Conditions / Mitochondrial Myopathies

Mitochondrial Myopathies

27 registered clinical trials studyying Mitochondrial Myopathies — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Validation of Nanosensor Oxygen Measurement NCT06819683	Children's Hospital of Philadelphia	Phase 1
Recruiting	Doxecitin and Doxribthymine in Adult Subjects With Thymidine Kinase 2 (TK2) Deficiency NCT06754098	Cristina Domínguez González	Phase 2
Completed	Exercise-mediated Rescue of Mitochondrial Dysfunctions Driving Insulin Resistance NCT06080594	Rigshospitalet, Denmark	N/A
Completed	Human Mitochondrial Stress-driven Obesity Resistance NCT06080568	Rigshospitalet, Denmark	—
Completed	Mitochondrial Dysfunctions Driving Insulin Resistance NCT06080581	Rigshospitalet, Denmark	—
Completed	Promoting Resilience in Stress Management (PRISM) and Clinical-focused Narrative (CFN) Pilot in Adults With Pr NCT06051448	Children's Hospital of Philadelphia	Phase 1 / Phase 2
Recruiting	Effect and Safety MABs Administration m.3243A>G Mutation Carriers NCT05962333	Maastricht University	Phase 2
Recruiting	Applying pGz in Mitochondrial Disease NCT05569122	Children's Hospital of Philadelphia	Phase 1
Recruiting	Validation of Oxygen Nanosensor in Mitochondrial Myopathy NCT04086329	Children's Hospital of Philadelphia	Phase 1
Recruiting	Home Based Personalized Training and Video Consultation in Mitochondrial Myopathies: Study of Efficacy and Tol NCT05346627	Centre Hospitalier Universitaire de Nice	N/A
Recruiting	mtDNA Mutation Load Analysis in Mesoangioblasts NCT05199740	Maastricht University	—
Completed	Genomic Profiling of Mitochondrial Disease - Imaging Analysis for Precise Mitochondrial Medicine NCT05012358	Mayo Clinic	—
Completed	Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nucl NCT05162768	Stealth BioTherapeutics Inc.	Phase 3
Completed	Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular D NCT05200702	Institut de Myologie, France	N/A
Completed	Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Di NCT05199246	Institut de Myologie, France	N/A
Completed	MABs Therapy m.3243A>G Mutation Carriers NCT05063721	Maastricht University	Phase 1
Completed	The KHENERGYZE Study NCT04165239	Khondrion BV	Phase 2
Completed	A Phase Ia/Ib, SAD and MAD Study of of KL1333 in Healthy Subjects and Patients With Primary Mitochondrial Dise NCT03888716	Abliva AB	Phase 1
Completed	NiaMIT Continuation With Early-stage Mitochondrial Myopathy Patients NCT04538521	University of Helsinki	N/A
Completed	Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation NCT03728777	Rigshospitalet, Denmark	N/A
Completed	Diagnostic Screening Tests and Potential Biomarkers in Mitochondrial Myopathies NCT03513835	Rigshospitalet, Denmark	—
Completed	Nicotinamide Riboside and Mitochondrial Biogenesis NCT03432871	Cambridge University Hospitals NHS Foundation Trust	N/A
Completed	The KHENERGY Study NCT02909400	Khondrion BV	Phase 2
Completed	RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR NCT02255422	Biogen	Phase 2
Completed	Nutritional Assessment in Mitochondrial Cytopathy NCT02375438	Insel Gruppe AG, University Hospital Bern	—
Completed	Niacin Supplementation in Healthy Controls and Mitochondrial Myopathy Patients NCT03973203	University of Helsinki	N/A
Recruiting	Global Registry and Natural History Study for Mitochondrial Disorders NCT05554835	LMU Klinikum	—